Ivan Dimov, CEO of Orca Bio, discusses historical medical cases where aggressive immune system resets (bone marrow transplants) cured other severe conditions alongside blood cancer.
Assertion Supported
Orca Bio clinical data shows practically zero transplant-related patient mortalities
“Well, we'll see, but the data so far suggests that we can bring it down to practically zero, right? Zero transplant related mortalities.”
Assertion Supported
Novartis shut down Irv Weissman's promising breast cancer cell therapy program
“They had really incredible results in terminal breast cancer patients, and it was ultimately acquired by Sandoz slash Novartis, and everyone thought that was going to be delivered to patients, but You know, they shut down the whole program two years later, and…”
Prediction Not checkable as stated
Safe immune resets could eventually treat tens of millions of patients
“And I think the, you know, ultimately, if this keeps progressing the way that we've seen it so far, there's no reason why you couldn't be helping tens of millions of patients.”
Assertion Supported
Orca Bio must compress multi-year drug distribution cycles into 72 hours
“If you look at a regular medicine from the moment you get the raw material until you ship it to the factory, you build the pills and then you ship, you have the whole distribution network and all the warehousing until it gets to the hospital and ultimately get…”
Insight
Single-dose curative cell therapies disrupt healthcare payment models requiring upfront billing
“Because you have to condense all of the regular payments that you do when you take a pill. You might take a pill for many years. You have to condense them all into one payment because at the end of the day, this is a single dose curative medicine.”
Assertion Not checkable as stated
Laser cell-sorting technology accelerates processing speeds by orders of magnitude
“So we have a whole stack of technologies that the technology you mentioned is sort of the accelerator to be able to broaden it out to really huge numbers of patients, where we're basically using lasers and light to move cells around and sort them, and, That ca…”